Marizyme, Inc. (MRZM)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 2, 2025
Marizyme Market Cap
Marizyme has a market cap or net worth of $132 as of October 9, 2026. It is the 52,817th most valuable company in the world and the 8,842nd biggest in the United States. Its market cap has decreased by 100.00% in one year.
Market Cap
132.00
Enterprise Value
26.59M
Revenue
183.42K
Global Rank
Country Rank
#8,842 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 3, 2010, Marizyme's market cap has decreased from 22.05M to 132.00, a decrease of -100.00%. That is a compound annual growth rate of -54.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 132.00 | -99.99% |
| Dec 30, 2024 | 1.08M | -76.87% |
| Dec 28, 2023 | 4.67M | -78.05% |
| Dec 30, 2022 | 21.28M | -70.17% |
| Dec 27, 2021 | 71.33M | -20.50% |
| Dec 31, 2020 | 89.72M | 768.82% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kiromic BioPharma | 157.00 |
| Regenicin | 153.00 |
| Poniard Pharmaceuticals | 150.00 |
| NexImmune | 139.00 |
| Seelos Therapeutics | 136.00 |
| PsyBio Therapeutics | 133.00 |
| HEALTHeUNIVERSE | 118.00 |
| RVL Pharmaceuticals | 111.00 |